July 6, 2022
TRIPS Council welcomes MC12 TRIPS waiver decision, discusses possible extension
At a meeting of the Council for Trade-Related Aspects of Intellectual Property Rights (TRIPS) on 6 July, WTO members welcomed the adoption of the TRIPS waiver decision on COVID-19 vaccines at the 12th Ministerial Conference (MC12) and began discussions on a possible extension to cover the production and supply of COVID-19 diagnostics and therapeutics. Trade officials also exchanged views on how to promote IP licensing to benefit small businesses, inventors and other individuals.
All copyrights for this article are reserved to Cosmetics design Europe